
Aditya Rajagopal discusses the challenges of medical device adoption and insights from his experience in the medtech industry.
In this episode of Medsider Radio, we sat down with Aditya Rajagopal , co-founder and CEO of Esperto Medical . Esperto is a Caltech spin-out utilizing compressed sensing technology with ultrasound to continuously and non-invasively measure blood pressure. Before Esperto, Aditya co-founded ChromaCode, a molecular diagnostics company, and was a researcher at Google[x], where he worked on novel medical imaging methods. Aditya also serves as part-time faculty at Caltech and USC, and holds BS, MS, and PhD degrees in Electrical Engineering from Caltech. In this interview, Aditya discusses why great science doesn’t necessarily make great companies, what it takes to win as a fast-follower in medtech, and how to sequence a platform technology without spreading resources too thin. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. And if you’re ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit…
Host: Scott Nelson
Guest: Aditya Rajagopal
Organizations: Esperto Medical, Caltech, ChromaCode, Google[x], USC
Explore listener stats, chart rankings, contacts and more on the Medsider: Learn from Medtech and Healthtech Founders and CEOs podcast page.